Standard cardiovascular screening was designed around male physiology and symptom patterns. Women experience vascular changes differently and often invisibly compared to conventional testing.

A woman in her early forties describes persistent fatigue, occasional breathlessness, and an unrelenting sense that something’s wrong. Her doctor checks the usual markers: blood pressure normal, cholesterol acceptable, and EKG regular. Everything looks fine, and she leaves with her concerns dismissed, even though vascular changes may already be happening.

This happens in medical offices daily because cardiovascular assessment in women has a fundamental problem: it relies on tests that weren’t designed with women’s physiology in mind. Research in the Journal of Women’s Health shows women develop vascular changes in smaller vessels that don’t appear on standard imaging. These microvascular shifts affect daily function and long-term health, but conventional tests miss them entirely.

Calroy Health Sciences developed advanced technologies to examine microvascular function at the cellular level. Their patented microfluidic chip technology reveals how blood vessels actually function, which matters especially for women whose vascular systems respond differently to hormonal and physiological changes.

The Testing Gender Gap

Dr. Joel Kahn, Integrative Cardiologist at the Kahn Center for Cardiac Longevity, says most family doctors do not routinely perform comprehensive vascular screening and often overlook how hormones impact women. 

“In my clinic, the questions I ask men and women are different,” Dr. Kahn explains. “I might ask a woman about preeclampsia and other pregnancy-induced blood pressure changes, pregnancy loss, age of menopause, or history of hormone replacement therapy. The questions are unique to women, but they’re often getting tested the same way as men.”

This standardized approach to testing can miss critical information. Studies have shown women typically develop cardiovascular diseases 7–10 years later than men. This change happens around the time women experience perimenopause and menopause, when hormonal changes that support a healthy endothelium and endothelial glycocalyx undergo significant shifts.

“Menopause and perimenopause are critical times to fully evaluate a woman,” Dr. Kahn emphasizes. “If a preventive health program hasn’t already started with lifestyle changes and optimal testing, this may be the time to adopt a plan for long-term cardiovascular wellness.”

What Standard Tests Actually Measure

Focusing on perimenopause and menopause is just the beginning. Conventional cardiovascular screening focuses on parameters that were validated primarily in male populations: blood pressure readings, cholesterol panels, EKGs measuring heart rhythm, and imaging of major arteries. These tests provide valuable information about macrovascular function, the large vessels visible on scans and responsive to blood pressure measurements.

But research shows women are more likely to experience coronary microvascular dysfunction (CMD). In fact, most people with CMD more frequently present with vascular changes in small vessels, while major arteries appear normal on angiography. Standard imaging is unable to detect these microscopic changes, leading to a diagnostic gap.

The Microcirculation Factor

The endothelial glycocalyx, a delicate layer coating the inside of every blood vessel, plays a particularly important role in microvascular function. This structure acts as both a protective barrier and a regulatory system, controlling what passes into vessel walls and triggering nitric oxide production for healthy blood flow.

The glycocalyx responds to various factors, including elevated blood sugar, hormonal changes, and oxidative stress. When this structure becomes compromised, microcirculation is affected even when major arteries remain healthy, explaining why individuals may experience functional limitations despite reassuring test results. 

Unique Risk Factors Often Overlooked in Women

Standard screening protocols ignore several cardiovascular risk factors that disproportionately affect women.

Pregnancy complications such as preeclampsia, gestational diabetes, and pregnancy-induced hypertension all signal increased vascular risk. When a woman sees a cardiologist a few years down the line, her pregnancy history rarely makes it into the assessment. The connection between what happened during pregnancy and current cardiovascular health gets lost.

Early menopause tells a similar story. Women who enter menopause before age 45 face different vascular health trajectories than those who transition later. But cardiovascular evaluations routinely skip this detail.

Then there’s lipoprotein(a), a genetic cholesterol factor that affects one in four people and substantially increases risk. Screening for it remains uncommon, despite clear evidence it matters.

The cost of overlooking these factors can show up years later as undiagnosed vascular changes that earlier intervention might have caught.

Symptom Recognition Challenges and Solutions

Women experiencing cardiovascular changes often describe different sensations than the classic presentations documented in male-focused research. A 2022 study published in the Journal of the American Heart Association found that women presenting with chest discomfort in emergency departments waited an average of 11 minutes longer to see a healthcare provider than men describing similar experiences and were less likely to receive standard cardiac testing.

While chest discomfort remains the most common experience for both sexes, women more frequently report:

• Persistent or unusual fatigue
• Shortness of breath during routine activities
• Nausea or digestive discomfort
• Pain in the jaw, neck, shoulder, or back
• General sense of feeling unwell without specific chest symptoms

These differences translate to delayed diagnosis, missed interventions, and functional limitations that standard testing protocols fail to address.

What Comprehensive Assessment Actually Requires

Women’s vascular assessment needs to move beyond the standardized approach built for men. That means asking different questions and measuring with greater precision.

It’s important to collect a reproductive history because pregnancy complications and menopausal timing are vascular risk indicators. Microvascular function matters as much as what shows up on arterial imaging, meaning lipoprotein(a) screening should be routine, not optional. The endothelial glycocalyx and nitric oxide pathways should also be checked to understand how well blood flows in the tiny capillaries, which gives different information than what is captured in the larger blood vessels.

The metrics that actually matter for women’s cardiovascular wellness extend far beyond what conventional testing measures, encompassing the microscopic vessels, protective structures, and hormonal factors that profoundly influence daily vitality and long-term vascular resilience.

FAQs

Why do women and men experience vascular changes differently?

While women have anatomical differences, including smaller hearts and narrower blood vessels, hormonal factors like estrogen also influence vascular health throughout their lives.

What is coronary microvascular dysfunction(CMD)?

Coronary microvascular dysfunction refers to changes in the smallest blood vessels of the heart where actual oxygen delivery occurs, often invisible to standard imaging that focuses on larger arteries.

How does menopause affect vascular health?

Menopause involves a significant shift in hormone levels that support the endothelium and endothelial glycocalyx, often accelerating vascular changes during the perimenopausal and menopausal transition.

What pregnancy complications indicate later cardiovascular risk?

Preeclampsia, gestational diabetes, and pregnancy-induced hypertension all signal increased vascular risk that persists long after pregnancy, yet these factors are often overlooked in later cardiovascular assessments.

What is lipoprotein(a) and why does it matter?

Lipoprotein(a) is a genetic cholesterol factor affecting 20-25% of individuals that significantly influences vascular health, yet screening for this factor remains uncommon in routine testing.

Can lifestyle approaches support microvascular health?

Regular physical activity, a diet emphasizing whole foods and natural nitrates, stress management, and adequate sleep all support healthy microcirculation and endothelial glycocalyx function.